<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/font-awesome.css">	

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Endocrine &amp; Metabolism</title>
	<meta name="description" content="Course Notes for Endocrine &amp; Metabolism">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>

	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div style="float: left;"><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

<div class="course-index">
	<a href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a>
</div>

        <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, October 6</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/intro-endocrinology.html">Introduction to Endocrinology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/endocrine-physiology-hormone-receptors-feedback-loops.html">Endocrine Physiology, Hormone Receptors & Feedback Loops</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-physiology.html">Thyroid Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-pharmacology.html">Thyroid Pharmacology</a></li></ul>
		<li class="day">Tuesday, October 7</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/07/clinical-presentation-evaluation-thyroid-disease.html">Clinical Presentation &amp; Evaluation of Thyroid Disease</a></li></ul>
		<li class="day">Wednesday, October 8</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/08/physiology-pathology-parathyroids.html">Physiology &amp; Pathology of the Parathyroids</a></li></ul>
		<li class="day">Thursday, October 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/hypercalcemia-hypocalcemia.html">Hypercalcemia &amp; Hypocalcemia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/metabolic-bone-disease.html">Metabolic Bone Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/thyroid-parathyroid-focal-cases.html">Thyroid/Parathyroid Focal Cases</a></li></ul>
		<li class="day">Friday, October 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/10/discussion-thyroid-calcium-cases.html">Discussion of Thyroid &amp; Calcium Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/10/wrap-up-multidisciplinary-head-neck-surgeons.html">Multidisciplinary with Head &amp; Neck Surgeons</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Tuesday, October 14</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/14/physiology-adrenal-glucocorticoids-mineralicorticoids-androgen-receptors.html">Physiology of Adrenal Hormones and Steroid Hormone Receptors</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/14/pharmacology-adrenal-glucocorticoids-mineralicorticoids-androgen-receptors.html">Pharmacology of Adrenal Hormones and Steroid Hormone Receptors</a></li></ul>
		<li class="day">Wednesday, October 15</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/15/adrenal-overproduction.html">Adrenal Overproduction</a></li></ul>
		<li class="day">Thursday, October 16</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/adrenal-insufficiency.html">Adrenal Insufficiency</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/review-adrenal-testing-imaging.html">Review of Adrenal Testing &amp; Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/sex-determination-differentiation.html">Sex Determination &amp; Differentiation</a></li></ul>
		<li class="day">Friday, October 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/disorders-sexual-differentiation-ambiguous-genitalia.html">Disorders of Sexual Differentiation &amp; Ambiguous Genitalia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/congenital-adrenal-hyperplasia.html">Congenital Adrenal Hyperplasia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/review-week-1-2-jeopardy.html">Review &ndash; Endocrine Jeopardy! Weeks 1 &amp; 2</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, October 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-introduction-feedback-loops.html">Pituitary Introduction &amp; Feedback Loops</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-overproduction-1.html">Pituitary Overproduction I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-overproduction-2.html">Pituitary Overproduction II</a></li></ul>
		<li class="day">Tuesday, October 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/pituitary-insufficiency.html">Pituitary Hormone Insufficiency</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/pituitary-gland-imaging.html">Pituitary Gland Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/adrenal-focus-cases.html">Adrenal Focal Cases</a></li></ul>
		<li class="day">Thursday, October 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/growth-development-normal-growth-short-stature.html">Growth &amp; Development &ndash; Normal Growth &amp; Short Stature</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/physiology-normal-puberty.html">Physiology of Normal Puberty</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/abnormalities-pubertal-development.html">Abnormalities of Pubertal Development</a></li></ul>
		<li class="day">Friday, October 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/glucose-homeostasis-pathophysiology-t1dm.html">Physiology of Glucose Homeostasis &amp; Pathophysiology of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/pharmacology-t1dm.html">Pharmacology of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/management-t1dm.html">Management of T1DM</a></li></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, October 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/acute-complications-t1dm.html">Acute Complications of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/introduction-physiology-epidemiology-t2dm.html">Introduction to T2DM &ndash; Physiology &amp; Epidemiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/pharmacology-t2dm.html">Pharmacology of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/diabetes-nutrition-doctors.html">Diabetes &amp; Nutrition for Doctors</a></li></ul>
		<li class="day">Tuesday, October 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/pcos-insulin-resistance-syndromes.html">PCOS &amp; Insulin Resistance Syndromes</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/pregnancy-diabetes.html">Pregnancy &amp; Diabetes</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/child-health-short-stature-disorders-puberty.html">Child Health Small Groups &ndash; Short Stature &amp; Disorders of Puberty</a></li></ul>
		<li class="day">Wednesday, October 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/therapy-t2dm.html">Therapy for T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/prevention-t2dm.html">Prevention of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/pediatrics-t2dm.html">T2DM in Pediatrics</a></li></ul>
		<li class="day">Thursday, October 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/complications-t2dm.html">Complications of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/prevention-complications-t2dm.html">Prevention of Complications in T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/t1dm-focal-cases.html">T1DM Focal Cases</a></li></ul>
		<li class="day">Friday, October 31</li>
		<ul></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Monday, November 3</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/11/03/polyendocrine.html">Polyendocrine Syndromes</a></li></ul>
		<li class="day">Tuesday, November 4</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/11/04/t2dm-focal-cases.html">T2DM Focal Cases</a></li></ul>
		<li class="day">Wednesday, November 5</li>
		<ul></ul>
	</ul>
</nav>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Metabolic Bone Disease</h1></div>
                <info datetime="2014-10-09">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#tehminaahmad">Tehmina Ahmad</a></span>
                    <span class="date">Thursday, October 09, 2014</span>
                </info>
                <div class="body"><blockquote>
  <h4 id="metabolic-bone-disease-notes"><strong>Metabolic Bone Disease Notes</strong></h4>
  <ul>
    <li>See <a href="https://dl.dropboxusercontent.com/u/157117/Class%20References/endo_12_13_Paul_NOTES_Metabolic_Bone_Disease.pdf">Metabolic Bone Disease</a> Notes.</li>
  </ul>
</blockquote>

<h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>
<ol>
  <li>Describe the pathophysiology of osteomalacia, osteoporosis and Paget’s Disease. </li>
  <li>Describe therapeutic options for osteomalacia, osteoporosis and Paget’s Disease. </li>
</ol>

<h1 id="osteomalacia">Osteomalacia</h1>
<hr />

<p><img class="right" src="https://dl.dropboxusercontent.com/spa/4hgd00vcv0woow6/5iwfdrfu.png" /></p>

<ul>
  <li><strong>Definition</strong>: <em>A defect in bone matrix mineralization.</em> 
    <ul>
      <li>In childhood, prior to the closure of the epiphyseal plates, this leads to <em>rickets.</em></li>
      <li>In adults it is known as <em>osteomalacia.</em> </li>
    </ul>
  </li>
  <li>A child with rickets can be seen to the right.</li>
</ul>

<h2 id="clinical-features"><strong>Clinical Features</strong></h2>
<ul>
  <li>Mineralization defects result in <em>weak bones</em> and <em>fractures</em>. </li>
  <li><em>Proximal muscle weakness</em> (myopathy) can be severe, leading to falls.</li>
  <li>Malabsorption syndromes (celiac disease patients) often also have or develop osteomalacia.</li>
</ul>

<h2 id="pathophysiology"><strong>Pathophysiology</strong></h2>
<ul>
  <li>Osteomalacia has several etiologies such as:
    <ol>
      <li>Vitamin disorders → <em>Vitamin D deficiency is the most common cause</em>.</li>
      <li>Mineral deficiencies</li>
      <li>Disorders of bone matrix</li>
      <li>Inhibitors of bone mineralization </li>
    </ol>
  </li>
</ul>

<h4 id="vitamin-disorders">1. <strong>Vitamin Disorders</strong></h4>
<ul>
  <li>Vitamin D is essential for calcium absorption.</li>
  <li>Main source is sunlight.  </li>
  <li>Calcium intake can prevent secondary hyperparathyroidism and reduce bone resorption.</li>
  <li><em>Older individuals</em> have difficulties getting enough Vitamin D.</li>
  <li><strong>Broadly speaking Vitamin D intake can be limited by:</strong>
    <ol>
      <li>Impaired formation or processing of Vitamin D.</li>
      <li>Lack of sunlight exposure.</li>
      <li>Inadequate Vitamin D intake .</li>
      <li>Inconsistent patient compliance with Vitamin D.</li>
      <li>Drug metabolism interference.</li>
    </ol>
  </li>
  <li><strong>Causes of decreased Vitamin D include:</strong>
    <ol>
      <li>Insufficient sunlight exposure.</li>
      <li>Nutritional deficiency.</li>
      <li>Malabsorption.</li>
      <li>Hydroxylation defects.</li>
      <li>Nephrotic Syndrome.</li>
      <li>Liver Disease (unable to perform the 25-hydroxylation).</li>
      <li>Chronic Renal Failure (unable to perform the 1α-hydroxylation).</li>
      <li>Anticonvulsant Therapy.</li>
    </ol>
  </li>
</ul>

<blockquote>
  <h4 id="clinical-note-daily-intake-of-vitamin-d"><strong>Clinical Note: Daily intake of Vitamin D</strong></h4>
  <ul>
    <li>The new 2010 recommended daily allowance (RDA) is <em>600 IU for those 1-70 years of age</em> and pregnant or breastfeeding women, and <em>800 IU for those over 71 years of age</em>. </li>
    <li>An adequate blood level of vitamin D is 20ng/mL, which can be achieved through daily skin exposure to sunlight.</li>
    <li>Multivitamin pills may contain 200-400 IU</li>
    <li>Calcium tablet containing vitamin D may have from 120 to 400 IU</li>
    <li>Supplements contain 400 and 1000 IU / tablet</li>
  </ul>
</blockquote>

<h4 id="mineral-deficiencies">2. <strong>Mineral Deficiencies</strong></h4>
<ul>
  <li><em>Calcium deficiency.</em></li>
  <li><em>Adults require 1000mg-1200mg of calcium a day &gt;19 years of age</em></li>
  <li><em>Phosphate deficiency</em> → decreased GI absorption or increased renal loss</li>
</ul>

<h4 id="disorders-of-bone-matrix">3. <strong>Disorders of Bone Matrix</strong></h4>
<ul>
  <li>Nothing more was said on this topic, just know it can play into the etiology of osteomalacia.</li>
</ul>

<h4 id="inhibitors-of-bone-mineralization">4. <strong>Inhibitors of Bone Mineralization</strong></h4>
<ol>
  <li><em>Aluminum</em>.</li>
  <li><em>Bisphosphonates</em>.
    <ul>
      <li>Bisphosphonates function to reduce bone turnover, but first generation bisphosphonates like etidronate actually <i>inhibit mineralization</i> if used for too long.</li>
    </ul>
  </li>
</ol>

<h2 id="a-clinical-approach-to-osteomalacia"><strong>A Clinical Approach to Osteomalacia</strong></h2>

<h4 id="history"><strong>History</strong></h4>
<ul>
  <li>Dietary history.</li>
  <li>Alcohol history.</li>
  <li>Significant weight loss within the last 6 months.
    <ol>
      <li>&gt; 10% loss of body weight.</li>
      <li>Either % ideal weight or % usual weight.</li>
      <li>Beware of patients with ascites/oedema, which adds weight (think of cirrhotic patients with portal hypertension).</li>
    </ol>
  </li>
</ul>

<h4 id="investigations-for-osteomalacia"><strong>Investigations for Osteomalacia</strong></h4>
<ul>
  <li><em>Laboratory:</em> ↓Ca, ↓ PO4, ↑alkaline phosphatase, ↓ urinary Ca.</li>
  <li><em>Radiology:</em> <strong>Looser-Milkman pseudofractures</strong> → thought to be healed microfractures </li>
  <li><em>Bone biopsy:</em> usually not necessary but considered <strong>gold standard</strong>.</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/all8ilxu.png" /></p>

<h4 id="treatment-for-osteomalacia"><strong>Treatment for Osteomalacia</strong></h4>
<ul>
  <li>Depends on the underlying cause.</li>
  <li>Vitamin D supplementation.</li>
  <li>PO4 supplements if low PO4.</li>
  <li>Ca supplements if low Ca.</li>
</ul>

<h1 id="pagets-disease">Paget’s Disease</h1>
<hr />

<ul>
  <li><strong>Definition</strong>: A metabolic disease characterized by <em>excessive bone destruction and repair</em>; a <strong>localized</strong> disorder of bone remodeling.</li>
</ul>

<p><img class="right" src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/gqy1b443.png" /></p>

<h4 id="clinical-features-1"><strong>Clinical Features</strong></h4>
<ul>
  <li><em>Usually asymptomatic</em> → routine X-ray finding or elevated alkaline phosphatase </li>
  <li><em>Severe bone pain</em> → pelvis, femur, tibia from lytic lesions that heal into sclerotic areas</li>
  <li><em>Skeletal deformities</em> → bowed tibia (<em>saber shins</em>), kyphosis, frequent fractures </li>
  <li><em>Skull involvement</em> → headaches, increased hat size, <em>deafness</em>, <em>frontal bossing</em> </li>
  <li>Increased warmth over involved bones due to increased vascularity</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/yyyreulg.png" />
<code>Some of the key clinical findings in Paget's disease, due to the accelerated breakdown and regrowth of bone. Top left: lytic lesions that heal into sclerotic areas. Top right: skull enlargement. Bottom left: frontal bossing. Bottom right: saber shins (bowed tibias).</code></p>

<blockquote>
  <h3 id="clinical-note-pagets-disease"><strong>Clinical Note: Paget’s Disease</strong></h3>
  <ul>
    <li>Paget’s disease is very common: affecting 5% of the population as a whole and 10% of the population &gt; 80 years of age. </li>
    <li><em>Second most common bone disease after osteoporosis</em> </li>
  </ul>
</blockquote>

<h4 id="pathophysiology-1"><strong>Pathophysiology</strong></h4>
<ul>
  <li>Initiated by increased osteoclastic activity leading to increased bone resorption. </li>
  <li>Osteoblastic activity increases in response to produce new bone that is structurally abnormal and fragile. </li>
  <li><em>Initiated by localized increases in osteoclast-mediated bone resorption with subsequent compensatory osteoblast increases in bone formation</em>.</li>
  <li>Results in a disorganized mosaic of woven and lamellar bone </li>
  <li>This structural change produces bone that is: 
    <ol>
      <li>expanded in size.</li>
      <li>less compact.</li>
      <li>more vascular.</li>
      <li>more susceptible to deformity or fracture.</li>
    </ol>
  </li>
</ul>

<h4 id="investigations-for-pagets-disease"><strong>Investigations for Paget’s Disease</strong></h4>
<ul>
  <li><strong>Laboratory</strong>: 
    <ul>
      <li><em>↑↑↑ alkaline phosphatase</em></li>
      <li><em>Alkaline Phosphatase is a marker of bone resorption!</em></li>
      <li>Normal or ↑ Ca, normal PO4.</li>
      <li>↑ Urinary hydroxyproline (indicates lots of bone resorption).</li>
    </ul>
  </li>
  <li><strong>Imaging</strong>: 
    <ul>
      <li>Evaluate extent of disease with <em>bone scan</em> </li>
      <li>Initial lesion may be destructive and radiolucent.</li>
      <li>Involved bones are expanded and denser that normal.</li>
      <li>Multiple fissure fractures in long bones.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="remember"><strong>Remember</strong></h4>
  <ul>
    <li><strong>Alkaline Phosphatase is a marker of bone resorption!</strong></li>
    <li>Hence, patients with Paget’s disease will have <em>very high alkaline phosphatase levels</em>.</li>
  </ul>
</blockquote>

<h4 id="complications-of-pagets-disease"><strong>Complications of Paget’s Disease</strong></h4>
<ul>
  <li>Fractures.</li>
  <li>Hypercalcemia and nephrolithiasis (kidney stones).</li>
  <li>Cranial nerve compression if skull involvement → deafness.</li>
  <li>Spinal cord compression.</li>
  <li><em>Osteosarcoma (1-3%) indicated by marked bone pain, new lytic lesions and increased alkaline phosphatase</em>.</li>
  <li>High output congestive heart failure due to increased vascularity.</li>
</ul>

<h4 id="treatment-of-pagets-disease"><strong>Treatment of Paget’s Disease</strong></h4>
<ul>
  <li><strong>Treat the symptoms</strong> → analgesias for pain relief </li>
  <li><strong>Bone protection</strong> → <em>bisphosphonates</em> → alendronate, risedronate, zoledronate.
    <ul>
      <li>Unlike osteomalacia, where the issue is that the bones are too soft, here it’s that the bone turnover is too high.</li>
      <li>Hence, where in osteomalacia, bisphosphonates are contraindicated, since they inhibit mineralization somewhat, here they’re critical, since they reduce turnover. </li>
    </ul>
  </li>
  <li>Calcitonin.</li>
</ul>

<h1 id="osteoporosis">Osteoporosis</h1>
<hr />

<h4 id="osteoporosis-1"><strong>Osteoporosis</strong></h4>
<ul>
  <li><em>Definition:</em> A <em>progressive systemic</em> skeletal disease characterized by <em>decreased bone mass and microarchitectural deterioration</em> of bone tissue leading to increased in bone fragility and risk of fracture. </li>
</ul>

<h4 id="clinical-features-2"><strong>Clinical Features</strong></h4>
<ul>
  <li>Commonly asymptomatic </li>
  <li>Pain, usually backache </li>
  <li><strong>Height loss</strong> → collapsed vertebrae, kyphosis </li>
  <li><strong>Fractures</strong> → <em>hip, vertebrae, wrist</em> </li>
</ul>

<blockquote>
  <h3 id="clinical-note-osteoporosis"><strong>Clinical Note: Osteoporosis</strong></h3>
  <ul>
    <li>1 in 4 women and 1 in 6 men &gt; 50 years of age have osteoporosis</li>
    <li>Total of 1.4 million Canadians are affected by osteoporosis and 2 million people are at increased risk of developing osteoporosis </li>
    <li><em>&lt; 20% of people who fracture go on to be assessed for osteoporosis (more than 79% are not diagnosed or treated for osteoporosis)</em></li>
    <li>Of the 30,000 hip fractures per year in Canada,
70% are due to osteoporosis</li>
    <li><em>Mortality rate</em> is 20% higher than average within one year of hip fracture</li>
    <li>By age 80, half of all women will have a vertebral fracture</li>
    <li><em>&lt;&lt; 500 grams of Ca (bone mass) is the threshold for fracture</em> </li>
  </ul>
</blockquote>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/9c29nq6_.png" /></p>

<h4 id="pathophysiology-2"><strong>Pathophysiology</strong></h4>
<ul>
  <li>Over time, both men and women lose bone mass. </li>
  <li><em>RANK ligand</em> is released from <em>osteoblasts</em>, and it functions to initiate precursor osteoclasts to mature.</li>
  <li>When PTH increases, it stimulates the release of RANK ligand from osteoblasts, increasing the number of osteoclasts, and hence the resorption of calcium.</li>
  <li><strong>Estrogen binds RANK ligand</strong>, limiting it’s release and hence limiting resorption by osteoclasts.
    <ul>
      <li>As a result, women lose bone mass faster than men due to menopause, because they no longer produce estrogen.</li>
      <li>Men are able to maintain bone mass longer than women due to testosterone conversion to estrogen and because they have a larger amount of bone mass to lose.</li>
    </ul>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/-_pxe8un.png" /></p>

<h3 id="clinical-note-osteoporosis-primary-vs-secondary"><strong>Clinical Note: Osteoporosis Primary vs. Secondary</strong></h3>
<ul>
  <li><strong>Primary Osteoporosis</strong>: 
    <ul>
      <li>Usually in women, within 20 years of menopause.</li>
      <li>Typically due to the mechanism described above; estrogen binds RANKL, so without estrogen production, osteoclast resorption increases.</li>
      <li>Affects mainly trabecular bone.</li>
    </ul>
  </li>
  <li><strong>Secondary Osteoporosis</strong>: 
    <ul>
      <li><em>Endocrinopathies</em> 
        <ol>
          <li>Hyperparathyroidism.</li>
          <li>Hyperthyroidism.</li>
          <li>Premature menopause or in men hypogonadism .</li>
          <li>Diabetes (this is still in up in the air).</li>
        </ol>
      </li>
      <li><em>Malignancy</em> </li>
      <li><em>Gastrointestinal disease</em> </li>
      <li><em>Drugs</em> 
        <ol>
          <li>steroids </li>
          <li>phenytoin </li>
        </ol>
      </li>
      <li><em>Other</em> 
        <ol>
          <li>Rheumatoid arthritis </li>
          <li>Renal disease </li>
          <li>Poor nutrition </li>
        </ol>
      </li>
    </ul>
  </li>
</ul>

<h4 id="fragility-fractures-in-osteoporosis"><strong>Fragility Fractures in Osteoporosis</strong></h4>
<ul>
  <li>Definition: A fracture that <em>occurs spontaneously or following a minor trauma</em> such as:
    <ol>
      <li>Fall from standing position (e.g. walking on ice)</li>
      <li>Fall from sitting position</li>
      <li>Fall from bed (&lt; 1 metre high)</li>
      <li>Fall after having missed 1–3 steps in a staircase</li>
      <li>After a movement outside of the typical plane of motion</li>
      <li>From coughing</li>
    </ol>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/nd9dt2hg.png" /></p>

<h4 id="risk-factors-for-fractures"><strong>Risk Factors for Fractures</strong></h4>
<ul>
  <li>Fragility fracture <em>after the age of 40</em></li>
  <li>Parental history of hip fracture</li>
  <li>Premature menopause</li>
  <li>Glucocorticoid use (&gt; 7.5 mg/d) &gt; 3 months in the prior year </li>
  <li>Lifestyle factors: smoking, excessive alcohol, and physical inactivity</li>
  <li>Weight loss since age 25 &gt;10%</li>
  <li>Poor nutrition, calcium intake, vitamin D status</li>
  <li>Recurrent falls</li>
</ul>

<h4 id="investigations-for-osteoporosis"><strong>Investigations for Osteoporosis</strong></h4>
<ul>
  <li><strong>Laboratory</strong>: Ca, PO4, alkaline phosphatase are usually normal unless secondary osteoporosis</li>
  <li><strong>Imaging</strong>: <strong>Bone densitometry</strong>.
    <ul>
      <li><em>Dual xray absorptiometry</em> (DEXA) most useful but single energy xray absorptiometry, ultrasound and quantitative CT also used.</li>
      <li>Lumbar spine and femur sites tested and compared to controls.</li>
    </ul>
  </li>
</ul>

<h4 id="treatment-of-osteoporosis"><strong>Treatment of Osteoporosis</strong></h4>
<ol>
  <li><strong>Prevention and lifestyle modifications:</strong> 
    <ul>
      <li><em>Weight bearing exercise.</em></li>
      <li><em>Calcium</em> → Total daily intake of Ca supplementation to 1200 mg/day.</li>
      <li><em>Vitamin D</em> → 400-1000 IU/day if &lt; 50 years of age, 800-2000IU/day. if &gt; 50 years of age*.</li>
      <li><em>Limit smoking and alcohol.</em> </li>
    </ul>
  </li>
  <li><strong>Measures to decrease further bone loss or resorption</strong>:
    <ul>
      <li><em>Bisphosphonates</em> → inhibitors of osteoclast </li>
      <li><em>Denosumab</em> → monoclonal antibody against RANK ligand and inhibits osteoclasts </li>
      <li><em>Selective estrogen receptor modulators</em> → SERM’s </li>
      <li><em>Postmenopusal estrogen replacement</em>.</li>
      <li><em>Calcitonin</em> → decreases osteoclast activity.</li>
    </ul>
  </li>
  <li><strong>Measures to increase bone mass</strong>:
    <ul>
      <li><em>Recombinant parathyroid hormone</em> → teriparatide.</li>
      <li>Teriparatide is identical to a portion of human parathyroid hormone (PTH) and intermittent use activates osteoblasts more than osteoclasts, which leads to an overall increase in bone.</li>
    </ul>
  </li>
</ol>

<blockquote>
  <h3 id="clinical-note-fracture-risk-assessment"><strong>Clinical Note: Fracture Risk Assessment</strong></h3>
  <ol>
    <li><em>Low peak bone mass</em> → small Caucasian or Asian female (&lt;57kg or BMI &lt;20), family history.</li>
    <li><em>Previous fragility fracture</em> → vertebral, hip, wrist </li>
    <li><em>Estrogen related bone mass</em> → early menopause, oophorectomy, amenorrhea, in men, hypogonadism.</li>
    <li><em>Advanced age</em>.</li>
    <li><em>Secondary to medical disease</em> → Hyperparathyroidism, Hyperthyroidism, Anticonvulsants, Glucocorticoids, Cancer chemotherapy, Malabsorption. </li>
    <li><em>Other</em> → Diet, Smoking, Alcohol, Minimal weight bearing activity </li>
  </ol>
</blockquote>

<h4 id="fracture-risk-assessment-tools"><strong>Fracture Risk Assessment Tools</strong></h4>
<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/-fz1i__k.png" /></p>

<h1 id="summary-chart">Summary Chart</h1>
<hr />

<ul>
  <li><strong>Know this chart well</strong>.</li>
</ul>

<table class="small">
	<tr>
		<th></th>
		<th style="text-align:left">Osteomalacia</th>
		<th style="text-align:left">Paget's Disease</th>
		<th style="text-align:left">Osteoporosis</th>
	</tr>
	<tr>
		<td style="text-align:left"><strong>Definition</strong></td>
		<td style="text-align:left">A defect in bone matrix mineralization.<ul><li>In children &rarr; <em>rickets</em>.</li><li>In adults &rarr; <em>osteomalacia</em></li></ul></td>
		<td style="text-align:left">A localized disorder of bone remodeling, resulting in excessive destruction and repair.</td>
		<td style="text-align:left">A progressive systemic skeletal disease resulting in decreased bone mass and deterioration of bone.</td>
	</tr>
	<tr>
		<td style="text-align:left"><strong>Pathophysiology</strong></td>
		<td style="text-align:left">Varied. Can be caused by <em>anything that reduces calcium levels</em>, or affects mineralization itself:<ul><li>Vitamin D disorders.</li><li>Calcium deficiencies.</li><li>Bone matrix disorders.</li><li>Inhibitors of bone mineralization (aluminum, bisphosphonates).</li></ul></td>
		<td style="text-align:left">A localized increase in <em>osteoclast</em> activity leads to a <em>compensatory increase in osteoblast activity</em>. In extreme cases, this leads to rapid breakdown and production, resulting in abnormal bone.<ul><li>Here, the osteoblast:osteoclast activity ratio is balanced, but both are excessive.</li></ul></td>
		<td style="text-align:left">An <i>imbalance</i> between the activity of osteoclasts and osteoblasts, typically seen in menopausal women where estrogen can no longer bind to RANKL (which stimulates osteoclast maturation).<ul><li>Here, the osteoblast:osteoclast activity ratio is unbalanced.</li></ul></td>
	</tr>
	<tr>
		<td style="text-align:left"><strong>Diagnosis</strong></td>
		<td style="text-align:left">
			<ul>
				<li>Ca <span style="color:red">&darr;</span>, PO4 <span style="color:red">&darr;</span></li>
				<li>Alkaline Phosphatase <span style="color:green">&uarr;</span></li>
				<li>Urinary Ca <span style="color:red">&darr;</span></li>
				<li>Radiological evidence of <em>Looser-Milkman pseudofractures</em>.</li>
				<li><em>Bone biopsy is considered the gold standard</em>, but is rarely done.</li>
			</ul>
		</td>
		<td style="text-align:left">
			<ul>
				<li>Ca normal/<span style="color:green">&uarr;</span>, PO4 &harr;</li>
				<li><em>Alkaline Phosphatase <span style="color:green">&uarr;&uarr;&uarr;</span></em></li>
				<li><em>Urine hydroxyproline <span style="color:green">&uarr;</span></em></li>
				<li><em>Bone scan</em> to determine the extent of involvement</li>
			</ul>
		</td>
		<td style="text-align:left">
			<ul>
				<li><em>Ca, PO4, and alkaline phosphatase are usually normal</em>, unless this is secondary.</li>
				<li><em>Bone density scan</em>.</li>
				<li><em>Spine X-ray</em> &rarr; to look for compression.</li>
			</ul>
		</td>
	</tr>
	<tr>
		<td style="text-align:left"><strong>Treatment</strong></td>
		<td style="text-align:left">Treatment depends on the etiology.
			<ul>
				<li>Vitamin D if they're Vitamin D deficient.</li>
				<li>Calcium if they're calcium deficient.</li>
				<li>Phosphate if they're phosphate deficient.</li>
			</ul>
		</td>
		<td style="text-align:left">
			<ul>
				<li><em>Pain relief</em> &rarr; analgesias.</li>
				<li><em>Bone Protection</em> &rarr; bisphosphonates.</li>
				<li><em>Calcitonin</em></li>
			</ul>
		</td>
		<td style="text-align:left">
			<ul>
				<li><em>Prevention &amp; Lifestyle Modifications</em> &rarr; weight bearing exercise, Calcium, Vitamin D, limit smoking and alcohol</li>
				<li><em>Decreasing Bone Loss</em> &rarr; bisphosphonates, denosumab (RANKL antibody), SERMs (estrogen receptor modulators), estrogen replacement, calcitonin.</li>
				<li><em>Increasing Bone Growth</em> &rarr; recombinant PTH (teriparatide).</li>
			</ul>
		</td>
	</tr>
</table>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/endocrinology/2014/10/09/hypercalcemia-hypocalcemia.html"><i class="fa fa-angle-left"></i> Hypercalcemia &amp; Hypocalcemia</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/endocrinology/2014/10/09/thyroid-parathyroid-focal-cases.html">Thyroid/Parathyroid Focal Cases <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/endocrinology/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/search.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>